Font: Financial Modeling Prep • Apr 09, 2026
(NYSE:BB) is a technology company that has transitioned from its legacy as a smartphone manufacturer to focusing on software solutions, particularly for automotive and industrial systems. Its QNX division, which develops embedded software, plays a crucial role in this strategy. BlackBerry competes with companies like Microsoft and Google in the software space.
On April 9, 2026, BlackBerry reported earnings per share (EPS) of $0.04, slightly below the estimated $0.05. Despite this, the company generated revenue of $156 million, surpassing the expected $144.7 million. This revenue reflects a 10% year-over-year growth, highlighting the company's strong performance.
Following the earnings report, BlackBerry shares surged by approximately 10%. The company exceeded expectations with adjusted earnings of $0.06 per share, as highlighted by Barron's. This positive market reaction underscores investor confidence in BlackBerry's strategic shift towards software.
A significant contributor to BlackBerry's success is its QNX division, which achieved record quarterly revenue of $78.7 million, marking a 20% increase from the previous year. This division's focus on embedded software for automotive and industrial systems is central to BlackBerry's growth strategy.
BlackBerry's financial health is further supported by a total adjusted gross margin of 78.2%, up by about five percentage points year-over-year. Adjusted EBITDA increased by 71% to $36.1 million, indicating strong operational efficiency. The company's net income for the quarter was $24.3 million, with a gross profit of $121.4 million.
|
CREG§>
Smart Powerr Corp.
|
$0.63
85.41%
|
|
RAYA§>
Erayak Power Solution Group Inc.
|
$0.95
107.94%
|
|
ISPC§>
iSpecimen Inc.
|
$0.13
-1.54%
|
|
CUE§>
Cue Biopharma, Inc.
|
$0.50
71.36%
|
|
WGRX§>
Wellgistics Health, Inc.
|
$0.12
13.21%
|
|
NVDA§>
NVIDIA Corporation
|
$188.75
2.63%
|
|
AIXI§>
Xiao-I Corporation
|
$1.22
23.07%
|
|
ZSPC§>
zSpace, Inc.
|
$0.07
-7.26%
|
|
FUSE§>
Fusemachines Inc.
|
$1.83
115.29%
|
|
QNCX§>
Quince Therapeutics, Inc.
|
$0.14
10.19%
|